NBE-Therapeutics AG picks up about $20 mln

Swiss biotech company NBE-Therapeutics AG has raised about $20 million in Series B financing. PPF Group led the round with participation from other investors that included Boehringer Ingelheim Venture Fund.

North AmericaUSBriefs